Noorik Biopharmaceuticals AG
Developing N-001 for the prevention of vontrast-induced acute kidney injury
Noorik Biopharmaceuticals, AG is a privately owned drug development company based in Switzerland. A virtual company, Noorik outsources all development work which allows for a lean organisation and efficient use of resources.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
13.12.2021
Federal government signs four contracts for the development of COVID-19 medicines (startupticker.ch)
No milestones
No Jobs
No videos and documents
No Awards
Noorik Biopharmaceuticals AG
Developing N-001 for the prevention of vontrast-induced acute kidney injury
Website:
www.noorik.com
Headquarter:
Riehen
Foundation Date:
September 2010
Technology:
- Biotech
Sectors:
- Drug development platforms